Back to Gastroenterology
Gastroenterologyv2004Evidence-Based

Ho Index for Ulcerative Colitis

Predicts outcome of medical therapy in severe ulcerative colitis by assessing risk of failure of corticosteroid therapy on day 3 of admission.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
ho index score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Ho Index for Ulcerative Colitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Ho Index Score = Stool Frequency Points + Colonic Dilatation Points + Hypoalbuminemia Points

Clinical Pearls & Practice Notes

  • Use in patients presenting with acute severe ulcerative colitis who are admitted to the hospital
  • Calculate on day 3 of admission for optimal predictive value
  • Mean stool frequency should be calculated over the previous 24 hours
  • Colonic dilatation is defined as transverse colon diameter ≥5.5cm on abdominal X-ray
  • Score has 85% sensitivity and 75% specificity at cutoff ≥4 for predicting non-response
  • Helps identify patients who may benefit from early second-line therapy or surgery

Evidence & Literature Citations

  1. Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, Satsangi J. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004 May 15;19(10):1079-87.
  2. Lynch RW, Churchhouse AM, Protheroe A, Arnott ID; UK IBD Audit Steering Group. Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data. Aliment Pharmacol Ther. 2016 Jun;43(11):1132-41.

Score Interpretation Ranges

Low Risk0 – 1 pts

Score 0-1

Intermediate Risk2 – 3 pts

Score 2-3

High Risk4 – 9 pts

Score ≥4

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.